Validation testing of next-gen genome analysis platform reveals potentially disruptive tech

A collaborative study by researchers from Baylor College of Medicine and Illumina has showcased the exceptional capabilities of the DRAGEN (Dynamic Read Analysis for GENomics) platform in comprehensive genome analysis.